Urokinase receptor (CD87) regulates leukocyte recruitment via β2 integrins in vivo

被引:252
作者
May, AE
Kanse, SM
Lund, LR
Gisler, RH
Imhof, BA
Preissner, KT
机构
[1] Max Planck Inst, Haemostasis Res Unit, Kerckhoff klin, D-61231 Bad Nauheim, Germany
[2] Rigshosp, Finsen Lab, DK-2100 Copenhagen, Denmark
[3] Basel Inst Immunol, CH-4001 Basel, Switzerland
[4] Ctr Med Univ Geneva, Dept Pathol, CH-1211 Geneva 4, Switzerland
关键词
leukocyte; endothelial cells; urokinase receptor; beta(2) integrin; inflammation;
D O I
10.1084/jem.188.6.1029
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The urokinase receptor (CD87; uPAR) is found in close association with beta(2) integrins on leukocytes. We studied the functional consequence of this association for leukocyte adhesion and migration. In vivo, the beta(2) integrin-dependent recruitment of leukocytes to the inflamed peritoneum of uPAR-deficient mice was significantly reduced as compared with wild-type animals. In vitro, beta(2) integrin-mediated adhesion ofleukocytes to endothelium was lost upon removal of uPAR from the leukocyte surface by phosphatidyl-inositol-specific phospholipase C. Leukocyte adhesion was reconstituted when soluble intact uPAR, but not a truncated form lacking the uPA-binding domain, was allowed to reassociate with the cell surface, uPAR ligation with a monoclonal antibody induced adhesion of monocytic cells and neutrophils to vascular endothelium by six- to eightfold, whereas ligation with inactivated uPA significantly reduced cell-to-cell adhesion irrespective of the beta(2) integrin-stimulating pathway. These data indicate that beta(2) integrin-mediated leukocyte-endothelial cell interactions and recruitment to inflamed areas require the presence of uPAR and define a new phenotype for uPAR-deficient mice. Moreover, uPAR ligation differentially modulates leukocyte adhesion to endothelium and provides novel targets for therapeutic strategies in inflammation-related vascular pathologies.
引用
收藏
页码:1029 / 1037
页数:9
相关论文
共 54 条
  • [11] REGULATION OF VASCULAR CELL-ADHESION MOLECULE-1 AND INTERCELLULAR-ADHESION MOLECULE-1 IN HUMAN VASCULAR SMOOTH-MUSCLE CELLS
    COUFFINHAL, T
    DUPLAA, C
    MOREAU, C
    LAMAZIERE, JMD
    BONNET, J
    [J]. CIRCULATION RESEARCH, 1994, 74 (02) : 225 - 234
  • [12] Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release?
    Deng, G
    Curriden, SA
    Wang, SJ
    Rosenberg, S
    Loskutoff, DJ
    [J]. JOURNAL OF CELL BIOLOGY, 1996, 134 (06) : 1563 - 1571
  • [13] Generation and characterization of urokinase receptor-deficient mice
    Dewerchin, M
    VanNuffelen, A
    Wallays, G
    Bouche, A
    Moons, L
    Carmeliet, P
    Mulligan, RC
    Collen, D
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (03) : 870 - 878
  • [14] INTERACTION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) WITH ITS CELLULAR RECEPTOR (U-PAR) INDUCES PHOSPHORYLATION ON TYROSINE OF A 38 KDA PROTEIN
    DUMLER, I
    PETRI, T
    SCHLEUNING, WD
    [J]. FEBS LETTERS, 1993, 322 (01) : 37 - 40
  • [15] Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans - A murine transgenic model
    Gyetko, MR
    Chen, GH
    McDonald, RA
    Goodman, R
    Huffnagle, GB
    Wilkinson, CC
    Fuller, JA
    Toews, GB
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (08) : 1818 - 1826
  • [16] THE UROKINASE RECEPTOR IS REQUIRED FOR HUMAN MONOCYTE CHEMOTAXIS IN-VITRO
    GYETKO, MR
    TODD, RF
    WILKINSON, CC
    SITRIN, RG
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (04) : 1380 - 1387
  • [17] STRUCTURE AND FUNCTION OF ADHESION RECEPTORS IN LEUKOCYTE TRAFFICKING
    HOGG, N
    BERLIN, C
    [J]. IMMUNOLOGY TODAY, 1995, 16 (07): : 327 - 330
  • [18] HOYERHANSEN G, 1992, J BIOL CHEM, V267, P18224
  • [19] CULTURE OF HUMAN ENDOTHELIAL CELLS DERIVED FROM UMBILICAL VEINS - IDENTIFICATION BY MORPHOLOGIC AND IMMUNOLOGICAL CRITERIA
    JAFFE, EA
    NACHMAN, RL
    BECKER, CG
    MINICK, CR
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1973, 52 (11) : 2745 - 2756
  • [20] KANSE SM, 1995, LAB INVEST, V72, P376